相关实验视频
Updated: Jul 1, 2025

00:07
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
7.3K
长非编码RNA作为乳头甲状腺癌的预后因素的进展
Hao-Nan Zhu1, Dong-Liang Song1, Si-Nan Zhang1
1Department of Clinical Medicine, Medical College, Shaoxing University, Shaoxing, Zhejiang 312000, China.
Pathology, research and practice
|March 10, 2024
概括
长非编码RNAs (lncRNAs) 在乳头甲状腺癌 (PTC) 的发展中至关重要. 本综述总结了 lncRNAs 的情况.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 乳头甲状腺癌 (PTC) 通常是缓慢增长的,但有些患者面临复发和不良预后.
- 由于缺乏有效的生物标志物,对PTC进行准确的风险分层是具有挑战性的.
- 长非编码RNAs (lncRNAs) 与癌症恶性和预后有关.
研究的目的:
- 审查乳头甲状腺癌中 lncRNAs 的生物功能.
- 为了确定与PTC预后相关的lncRNAs.
- 探索BRAF抑制剂耐药性,瘤脱差和淋巴结转移中的lncRNA机制.
主要方法:
- 关于皮肤状甲状腺癌中lncRNAs研究的综合文献综述.
- 分析lncRNA在PTC病原和进展中的作用.
- 调查lncRNA参与治疗耐药性和转移.
主要成果:
- lncRNAs在PTC的产生和进展中发挥着不同的作用.
- 特定的lncRNA与PTC的不良预后和临床结果有关.
- lncRNAs与药物耐药性,脱差和PTC转移有关.
结论:
- 在乳头甲状腺癌中, lncRNAs 是显著的调节者.
- 预后相关的 lncRNAs 作为风险分层的生物标志物具有潜力.
- 了解lncRNA机制可以指导治疗策略并改善PTC患者的治疗结果.
相关概念视频
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
Non-LTR Retrotransposons
11.5K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.5K
The Nucleolus
8.8K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
8.8K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K

